Bioequivalence study of GP-IMP-001 with regards to reference product
Gebro-I-56.1
Phase 1 other active
Quick answer
Bioequivalence study of GP-IMP-001 with regards to reference product for healthy volunteers is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- healthy volunteers
- Phase
- Phase 1
- Modality
- other
- Status
- active